Literature DB >> 23925378

Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate ≥ 60 ml/min per 1.73 m2.

Jacques Reynes1, Amandine Cournil, Hélène Peyriere, Christina Psomas, Elsa Guiller, Marlène Chatron, Jean-Paul Cristol, Stéphanie Badiou.   

Abstract

OBJECTIVE: To assess the frequency of glomerular and tubular proteinuria in a cohort of HIV-infected patients, and to determine the factors associated with each type of injury.
DESIGN: Cross-sectional study of 1210 consecutive HIV-infected adults followed in HIV outpatient unit (Montpellier/France).
METHODS: Spot urine protein to creatinine (uPCR), albumin to creatinine (uACR) and albumin to protein (uAPR) ratios were assessed. Glomerular injury was defined as uACR at least 30 mg/g or uPCR at least 200 mg/g with uAPR at least 0.4. Tubular injury was defined as uPCR 200 mg/g or more with uAPR less than 0.4. Multivariate logistic regression identified independent factors of each type of proteinuria, in the 1158 patients with estimated glomerular filtration rate (eGFR) at least 60 ml/min per 1.73 m, using re-expressed modification of diet in renal disease equation.
RESULTS: Frequency of proteinuria was 18.2% among patients with eGFR at least 60 ml/min per 1.73 m consisting in tubular proteinuria for 50.7% of them. Factors associated with glomerular proteinuria were age [OR 1.34/10-year increment (95%CI: 1.08-1.66)], diabetes [OR 3.37 (95%CI: 1.53-7.44)], and arterial hypertension [OR 2.52 (95%CI: 1.36-4.66)]. Factors associated with tubular proteinuria were age [OR 1.43 (95%CI: 1.14-1.79)], current tenofovir use [OR 3.52 (95%CI: 1.86-6.65)], hepatitis C co-infection [OR 1.62 (95%CI: 1.00-2.65)], AIDS stage [OR 1.83 (95%CI: 1.18-2.82)], CD4 cell count less than 200 per μl [OR 2.48 (95%CI: 1.31-4.70)].
CONCLUSION: This study distinguished risk factors for tubular injury, mainly related to HIV disease and its treatment (tenofovir), and glomerular injury, linked to non HIV-related variables (age, diabetes, hypertension). Measuring uPCR, uACR and uAPR may help with the detection and specific management of early chronic kidney disease in HIV-infected patients having normal or sub-normal eGFR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23925378     DOI: 10.1097/QAD.0b013e32835fac51

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

1.  Longitudinal Assessment of Proximal Tubular Dysfunction in HIV Seropositive and Seronegative Persons: Correlates and Implications.

Authors:  Kerry M Sheets; Mohamed G Atta; Derek M Fine; Katie Zook; Allison M Mcfall; Michelle M Estrella; George J Schwartz; Gregory M Lucas
Journal:  J Acquir Immune Defic Syndr       Date:  2017-05-01       Impact factor: 3.731

2.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

3.  The role of albuminuria in the follow-up of HIV-infected pediatric patients.

Authors:  Angela Deyà-Martínez; Antoni Noguera-Julian; Jordi Vila; Anna Vila; Anna Valls; Emília Sánchez; Rafael Jiménez; Clàudia Fortuny
Journal:  Pediatr Nephrol       Date:  2014-04-16       Impact factor: 3.714

4.  Medium-grade tubular proteinuria is common in HIV-positive patients and specifically associated with exposure to tenofovir disoproxil Fumarate.

Authors:  A J Zeder; R Hilge; S Schrader; J R Bogner; U Seybold
Journal:  Infection       Date:  2016-06-02       Impact factor: 3.553

Review 5.  A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection.

Authors:  Stephen G Holt; David M Gracey; Miriam T Levy; David W Mudge; Ashley B Irish; Rowan G Walker; Richard Baer; Jacob Sevastos; Riaz Abbas; Mark A Boyd
Journal:  AIDS Res Ther       Date:  2014-11-10       Impact factor: 2.250

6.  Renal dysfunction among adult HIV/AIDS patients on antiretroviral therapy at a tertiary facility in Ghana.

Authors:  Dorcas Obiri-Yeboah; Yaw Asante Awuku; Wonderful Alofa; Alice Charwudzi; Ebenezer Aniakwa-Bonsu; Evans Obboh; Paul Nsiah
Journal:  BMC Nephrol       Date:  2018-11-21       Impact factor: 2.388

7.  Tenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana.

Authors:  David R Chadwick; Fred S Sarfo; Elaine S M Kirk; Dorcas Owusu; George Bedu-Addo; Victoria Parris; Ann Lorraine Owusu; Richard Phillips
Journal:  BMC Nephrol       Date:  2015-12-01       Impact factor: 2.388

8.  Long-Term Follow-Up of Proteinuria and Estimated Glomerular Filtration Rate in HIV-Infected Patients with Tubular Proteinuria.

Authors:  Hélène Peyriere; Amandine Cournil; Marie-Laure Casanova; Stéphanie Badiou; Jean-Paul Cristol; Jacques Reynes
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

9.  Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study.

Authors:  Anna Bonjoch; Jordi Puig; Nuria Pérez-Alvarez; Javier Juega; Patricia Echeverría; Bonaventura Clotet; Ramón Romero; J Bonet; E Negredo
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  Urine alpha1-microglobulin is a better marker for early tubular dysfunction than beta2-microglobulin among tenofovir-exposed human immunodeficiency virus-infected men who have sex with men.

Authors:  Jing Kang; Jing Liu; Haibo Ding; Xiaolin Li; Qi Wang; Xiaolin Guo; Wenqing Geng; Hong Shang
Journal:  Braz J Infect Dis       Date:  2015-06-26       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.